Thirty years of hemophilia treatment in the Netherlands, 1972-2001
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Since the introduction of replacement therapy in the early 1960s by the infusion of plasma-derived factor VIII and IX preparations, important changes have occurred for hemophilia patients. We studied the medical and social developments over 30 years of hemophilia treatment. Since 1972, 5 cross-sectional national postal surveys among all hemophilia patients in the Netherlands were performed, the latest in 2001. The prestructured questionnaires included items on treatment, the presence of inhibitory antibodies against factor VIII or IX, the annual number of bleeding episodes, use of inpatient hospital care, and hepatitis C and HIV infections. Response rate in 2001 was 70%. Young patients (<16 years) with severe hemophilia showed the largest increase in use of prophylaxis, from 34% in 1972 to 86% in 2001. The occurrence of hemorrhages has gradually decreased. Hospital admissions decreased from 47% of all patients in 1972 to 18% in 2001. Our study shows that the treatment of patients with severe hemophilia in the Netherlands has focused on the use of prophylactic treatment, especially in children. This has resulted in a decrease in bleeding frequency and an improvement of the medical and social circumstances of patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The hemophilias--from royal genes to gene therapy
Mannucci, P. M., & Tuddenham, E. G. D. (2001) · New England Journal of Medicine · doi:10.1056/nejm200106073442307 · Cited by 1,110 · cited 5×
“Ankle joints Left 74 (18) 9 (5) Right 76 (18) 10 (6) Knee joints Left 67 (16) 13 (7) Right 69 (16) 17 (10) Elbow joints Left 34 (8) 5 (3) Right 45 (11) 5 (3)”
InfluentialHemophilia treatment in historical perspective: a review of medical and social developments
Rosendaal, F. R., Smit, C., & Briët, E. (1991) · Annals of Hematology · doi:10.1007/bf01714977 · Cited by 83
Cited by
A study of variations in the reported haemophilia A prevalence around the world
STONEBRAKER, J. S., BOLTON‐MAGGS, P. H. B., MICHAEL SOUCIE, J., WALKER, I., & BROOKER, M. (2010) · Haemophilia · doi:10.1111/j.1365-2516.2009.02127.x · Cited by 296
DEN UIJL, I. E. M., FISCHER, K., VAN DER BOM, J. G., GROBBEE, D. E., ROSENDAAL, F. R., & PLUG, I. (2011) · Haemophilia · doi:10.1111/j.1365-2516.2010.02383.x · Cited by 214
Self-citationAdherence to prophylaxis and bleeding outcome in haemophilia: a multicentre study
Schrijvers, L. H., Beijlevelt ‐ van der Zande, M., Peters, M., Lock, J., Cnossen, M. H., Schuurmans, M. J., & Fischer, K. (2016) · British Journal of Haematology · doi:10.1111/bjh.14072 · Cited by 64
A feasibility study on two tailored interventions to improve adherence in adults with haemophilia
Hoefnagels, J. W., Fischer, K., Bos, R. A. T., Driessens, M. H. E., Meijer, S. L. A., Schutgens, R. E. G., & Schrijvers, L. H. (2020) · Pilot and Feasibility Studies · doi:10.1186/s40814-020-00723-w · Cited by 24
Metadata
- Authors
- Plug, I.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2004-12-01
- Volume
- 104
- Issue
- 12
- Pages
- 3494-3500
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W1963633512
- Cited by
- 118
- References
- 2
- FWCI
- 2.26
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Thirty years of hemophilia treatment in the Netherlands, 1972-2001. https://app.cochat.ai/papers/10.1182/blood-2004-05-2008
- The paper
- Plug, I. (2004). Thirty years of hemophilia treatment in the Netherlands, 1972-2001. Blood. https://doi.org/10.1182/blood-2004-05-2008
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.